MAMasaki Asada

Masaki Asada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masaki Asada has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Representing a Heterogeneous Pharmaceutical Knowledge-Graph with Textual Information

    by Masaki Asada, Nallappan Gunasekaran, Makoto Miwa, Yutaka Sasaki

    We deal with a heterogeneous pharmaceutical knowledge-graph containing textual information built from several databases. The knowledge graph is a heterogeneous graph that includes a wide variety of concepts and attributes, some of which are provided in the form of textual pieces of information which have not been targeted in the conventional graph completion tasks. To investigate the utility of textual information for knowledge graph completion, we generate embeddings from textual descriptions given to heterogeneous items, such as drugs and proteins, while learning knowledge graph embeddings. We evaluate the obtained graph embeddings on the link prediction task for knowledge graph completion, which can be used for drug discovery and repurposing. We also compare the results with existing methods and discuss the utility of the textual information.


  • Open Access

    Using drug descriptions and molecular structures for drug–drug interaction extraction from literature

    by Masaki Asada, Makoto Miwa, Yutaka Sasaki

    Motivation: Neural methods to extract drug–drug interactions (DDIs) from literature require a large number of annotations. In this study, we propose a novel method to effectively utilize external drug database information as well as information from large-scale plain text for DDI extraction. Specifically, we focus on drug description and molecular structure information as the drug database information. Results: We evaluated our approach on the DDIExtraction 2013 shared task dataset. We obtained the following results. First, large-scale raw text information can greatly improve the performance of extracting DDIs when combined with the existing model and it shows the state-of-the-art performance. Second, each of drug description and molecular structure information is helpful to further improve the DDI performance for some specific DDI types. Finally, the simultaneous use of the drug description and molecular structure information can significantly improve the performance on all the DDI types. We showed that the plain text, the drug description information and molecular structure information are complementary and their effective combination is essential for the improvement. Availability and implementation: Our code is available at https://github.com/tticoin/DESC_MOL-DDIE.